Aprepitant EP Impurity C

Synonyma:: Aprepitant impurity 09;Aprepitant EP Impurity C;5-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4'-fluoro-[1,1'-biphenyl]-4-yl)morpholino)methyl)-2,4-dihydro-3H-1,2,4-triazol-3-one;5-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4'-fluoro-[1,1'-biphenyl]-4-yl)morpholino)methyl)-2,4-dihydro-3H-1,2,4-triazol-3-one;3H-1,2,4-Triazol-3-one, 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4'-fluoro[1,1'-biphenyl]-4-yl)-4-morpholinyl]methyl]-1,2-dihydro-;3-(((2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4'-fluoro-[1,1'-biphenyl]-4-yl)morpholino)methyl)-1H-1,2,4-triazol-5(4H)-one (Aprepitant Impurity);3-(((2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4'-fluoro-[1,1'-biphenyl]-4-yl)morpholino)methyl)-1H-1,2,4-triazol-5(4H)-one (Aprepitant Impurity)

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 28

Aprepitant EP Impurity C Eigenschaften

4-?Defluoro-?4-?(p-?fluorophenyl) Aprepitant is a triadimefon derivative used for inhibiting chlamdyia trachomatis growth.

Global( 28)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
CR Corporation Limited	+8613062833949	fred.wen@crcorporation.cn	China	8647	58
China National Standard Pharmaceutical Corporation Limited	+8615391658522	overseasales@yongstandards.com	China	11922	58
ShenZhen H&D Pharmaceutical Technology Co., LTD	+8618627948422	sale@hdimpurity.com	China	3389	58
Scinova Biotech(Guangzhou) Co., Ltd.	13268215580	scinova_sales@163.com	China	7023	58
Shanghai Kewel Chemical Co., Ltd.	021-64609169 18901607656	greensnown@163.com	China	9906	50
Hubei Yangxin Medical Technology Co., Ltd.	15374522761	3003392093@qq.com	China	8368	55
Klong Industrial Co., Ltd	519-68231162 13961227312	info@klongchem.com	China	164	58
TOSUN PHARM	020-61855200 13326451905	260366801@qq.com	China	7760	58
BOC Sciences	--	info@bocsci.com	USA	0	65
Guangzhou Dreampharm Biotechnology Co., Ltd.	020-36607679 17825480238	3008233717@qq.com	China	9919	12

3H-1,2,4-Triazol-3-one, 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4'-fluoro[1,1'-biphenyl]-4-yl)-4-morpholinyl]methyl]-1,2-dihydro-
5-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4'-fluoro-[1,1'-biphenyl]-4-yl)morpholino)methyl)-2,4-dihydro-3H-1,2,4-triazol-3-one
3-(((2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4'-fluoro-[1,1'-biphenyl]-4-yl)morpholino)methyl)-1H-1,2,4-triazol-5(4H)-one (Aprepitant Impurity)
Aprepitant impurity 09
Aprepitant EP Impurity C
5-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4'-fluoro-[1,1'-biphenyl]-4-yl)morpholino)methyl)-2,4-dihydro-3H-1,2,4-triazol-3-one
3-(((2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4'-fluoro-[1,1'-biphenyl]-4-yl)morpholino)methyl)-1H-1,2,4-triazol-5(4H)-one (Aprepitant Impurity)
2348441-63-2